2022 - Research.com Best Female Scientist Award
Montserrat Garcia-Closas focuses on Internal medicine, Breast cancer, Oncology, Genome-wide association study and Genetics. The Internal medicine study which covers Endocrinology that intersects with Urinary bladder. As a part of the same scientific study, she usually deals with the Breast cancer, concentrating on Genetic predisposition and frequently concerns with Gene mutation.
Her biological study spans a wide range of topics, including Prospective cohort study, Serous fluid, Pathology, Prostate cancer and Family history. Her Genome-wide association study study results in a more complete grasp of Single-nucleotide polymorphism. Her Genetics research focuses on subjects like Cancer research, which are linked to Enhancer RNAs, Chromatin immunoprecipitation, Transcription factor, Enhancer and Regulation of gene expression.
Her primary areas of study are Breast cancer, Internal medicine, Oncology, Single-nucleotide polymorphism and Genome-wide association study. Her Breast cancer study incorporates themes from Tissue microarray, Genetic predisposition, Bioinformatics and Risk factor. Her work on Internal medicine is being expanded to include thematically relevant topics such as Endocrinology.
Her Oncology study integrates concerns from other disciplines, such as Immunology, Pathology, Ovarian cancer, Gynecology and Endometrial cancer. Her Single-nucleotide polymorphism research incorporates elements of Allele and Haplotype. Her Genome-wide association study study is focused on Genetics in general.
Montserrat Garcia-Closas mostly deals with Breast cancer, Internal medicine, Oncology, Cancer and Odds ratio. The study incorporates disciplines such as Polygenic risk score, Genome-wide association study and Case-control study in addition to Breast cancer. Her work in the fields of Confidence interval, Hazard ratio and Breast disease overlaps with other areas such as In patient.
Her Oncology research is multidisciplinary, incorporating elements of Body mass index, Germline, Proportional hazards model, Prospective cohort study and Single-nucleotide polymorphism. Her Cancer research integrates issues from Myeloid, Cancer research, CHEK2, Whole genome sequencing and Lung cancer. Her Odds ratio research also works with subjects such as
Her primary areas of investigation include Breast cancer, Internal medicine, Oncology, Genome-wide association study and Odds ratio. Montserrat Garcia-Closas combines subjects such as Case-control study, Family history, Disease and Risk factor with her study of Breast cancer. Montserrat Garcia-Closas interconnects Germline mutation, Cohort study, Colorectal cancer, Single-nucleotide polymorphism and Prostate cancer in the investigation of issues within Oncology.
Montserrat Garcia-Closas has begun a study into Genome-wide association study, looking into Genetics and Genotype. The Genotype study combines topics in areas such as Endometrial cancer and Locus. Her studies deal with areas such as Genetic heterogeneity, Linkage disequilibrium, Genetic predisposition and Genetic testing as well as Estrogen receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
Sholom Wacholder;Stephen Chanock;Montserrat Garcia-Closas;Laure El ghormli.
Journal of the National Cancer Institute (2004)
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks.
PLOS Medicine (2010)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
Montserrat García-Closas;Núria Malats;Debra Silverman;Mustafa Dosemeci.
The Lancet (2005)
Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature
Michelle D. Althuis;Jennifer H. Fergenbaum;Montserrat Garcia-Closas;Louise A. Brinton.
Cancer Epidemiology, Biomarkers & Prevention (2004)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox;Alison M. Dunning;Montserrat Garcia-Closas;Sabapathy Balasubramanian.
Nature Genetics (2007)
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
Gilles Thomas;Kevin B Jacobs;Kevin B Jacobs;Peter Kraft;Meredith Yeager;Meredith Yeager.
Nature Genetics (2009)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: